The University of Vermont Medical Center is a five-campus academic medical facility under the corporate umbrella of The University of Vermont Health Network corporate that is anchored by a 562-bed hospital. UVM is located in Burlington, Vermont, and serves as both a regional referral center and a community hospital.

There are 562 beds in University of Vermont Medical Center.

During the past decade, University of Vermont Medical Center conducted 215 clinical trials. In the 10-year time frame, 215 clinical trials started and 148 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 78 clinical trials started and 80 clinical trials were completed. i.e. 102.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Vermont Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 52 trials, followed by "National Cancer Institute (NCI)" with 44 trials sponsored, "Gynecologic Oncology Group" with 25 trials sponsored, "SWOG Cancer Research Network" with 24 trials sponsored and "University of Vermont" with 24 trials sponsored. Other sponsors include 234 different institutions and companies that sponsored additional 115 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Vermont Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 169 trials as a collaborator, "NRG Oncology" with 32 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 18 trials as a collaborator, "SWOG Cancer Research Network" with 11 trials as a collaborator and "Canadian Cancer Trials Group" with 9 trials as a collaborator. Other collaborators include 241 different institutions and companies that were collaborators in the rest 166 trials.

According to Clinical.Site data, the most researched conditions in "University of Vermont Medical Center" are "Breast Cancer" (23 trials), "Lymphoma" (17 trials), "Heart Failure" (15 trials), "Leukemia" (14 trials) and "Prostate Cancer" (13 trials). Many other conditions were trialed in "University of Vermont Medical Center" in a lesser frequency.

Most popular intervention types in "University of Vermont Medical Center" are "Drug" (265 trials), "Other" (109 trials), "Biological" (84 trials), "Procedure" (73 trials) and "Radiation" (68 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (49 trials), "Quality-of-Life Assessment" (37 trials), "Laboratory Biomarker Analysis" (36 trials), "Carboplatin" (26 trials) and "Questionnaire Administration" (26 trials). Other intervention names were less common.

The vast majority of trials in "University of Vermont Medical Center" are 312 trials for "All" genders, 74 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are NaN active trials in "University of Vermont Medical Center". undefined are not yet recruiting, 67 are recruiting, 83 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 194 completed trials in University of Vermont Medical Center, 3 suspended trials, and 41 terminated clinical trials to date.

Out of the total trials that were conducted in University of Vermont Medical Center, 20 "Phase 1" clinical trials were conducted, 131 "Phase 2" clinical trials and 154 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 57 trials that are defined as “Not Applicable".

University of Vermont Medical Center has several departments that took part in Clinical trials: "University of Vermont Children's Hospital" - 6 trials, "University of Vermont , Department of Neurology Given Building C-219 , 89 Beaumont Avenue" - 4 trials, "University of Vermont Medical Center Gastro" - 3 trials, "University of Vermont Medical Center; Investigational Drug Service, Pharmacy Department/Baird 1" - 2 trials, "Vermont Cancer Center at Fletcher Allen Health Care" - 2 trials